VRTX Insider Trading Activity and SEC Form 4 Filings
Trump's trades in VRTX
From his financial disclosures
$617K+
13 purchases
$50K+
8 sales
Purchase
Jul 23, 2026
Reported 61d later
$15K - $50K
Purchase
Jun 15, 2026
Reported 68d later
$1K - $15K
Sale
Jun 12, 2026
Reported 71d later
$1K - $15K
Purchase
Jun 3, 2026
Reported 80d later
$1K - $15K
Sale
May 22, 2026
Reported 40d later
$15K - $50K
Sale
May 18, 2026
Reported 44d later
$15K - $50K
Many orders in these accounts are placed by the account manager. See all 21 trades
VRTX insider trading summary
Over the past 12 months, insiders at Vertex Pharmaceuticals Inc / Ma (VRTX) reported 91 sales worth $156.5M by 13 insiders and no open-market purchases on SEC Form 4. Net insider selling was $156.5M.
Latest VRTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sell | $787K (1,500 @ $524.99) |
| Jul 2, 2026 | Duncan McKechnie | EVP, Chief Commercial Officer | Sell | $800K (1,541 @ $519.00) |
| Jul 1, 2026 | Joy Liu | EVP and Chief Legal Officer | Sell | $416K (828 @ $502.71) |
| Jun 18, 2026 | Carmen Bozic | EVP and CMO | Sell | $471K (1,020 @ $462.17) |
| Jun 15, 2026 | Carmen Bozic | EVP and CMO | Sell | $1.8M (4,062 @ $450.00) |
| Jun 5, 2026 | Carmen Bozic | EVP and CMO | Sell | $785K (1,745 @ $450.00) |
| Jun 1, 2026 | Joy Liu | EVP and Chief Legal Officer | Sell | $364K (828 @ $439.91) |
| May 29, 2026 | Carmen Bozic | EVP and CMO | Sell | $888K (1,974 @ $450.00) |
| May 15, 2026 | Carmen Bozic | EVP and CMO | Sell | $614K (1,354 @ $453.45) |
| May 15, 2026 | Mark E. Bunnage | EVP, Chief Scientific Officer | Sell | $15K (33 @ $453.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.